Henry Schein, Inc. (0L3C.L)
USD 72.28
(-1.94%)
USD 72.28
(-1.94%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.74 Billion USD | 83.1% |
| 2022 | 1.49 Billion USD | 23.04% |
| 2021 | 1.21 Billion USD | 21.37% |
| 2020 | 1 Billion USD | 0.41% |
| 2019 | 998.34 Million USD | -49.18% |
| 2018 | 1.96 Billion USD | 17.9% |
| 2017 | 1.66 Billion USD | 36.69% |
| 2016 | 1.21 Billion USD | 50.53% |
| 2015 | 809.71 Million USD | 10.69% |
| 2014 | 731.49 Million USD | 50.77% |
| 2013 | 485.18 Million USD | -9.02% |
| 2012 | 533.27 Million USD | 20.83% |
| 2011 | 441.35 Million USD | 0.01% |
| 2010 | 441.3 Million USD | 64.75% |
| 2009 | 267.86 Million USD | -37.41% |
| 2008 | 427.98 Million USD | -6.26% |
| 2007 | 456.57 Million USD | -8.57% |
| 2006 | 499.37 Million USD | -4.81% |
| 2005 | 524.62 Million USD | -2.04% |
| 2004 | 535.55 Million USD | 108.87% |
| 2003 | 256.41 Million USD | 2.56% |
| 2002 | 250.01 Million USD | -4.36% |
| 2001 | 261.41 Million USD | -5.52% |
| 2000 | 276.69 Million USD | -23.9% |
| 1999 | 363.6 Million USD | 73.64% |
| 1998 | 209.4 Million USD | 82.88% |
| 1997 | 114.5 Million USD | 187.69% |
| 1996 | 39.8 Million USD | -7.66% |
| 1995 | 43.1 Million USD | -29.46% |
| 1994 | 61.1 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 2.83 Billion USD | 4.42% |
| 2024 Q1 | 2.71 Billion USD | -0.84% |
| 2023 Q1 | 1.65 Billion USD | 10.82% |
| 2023 Q3 | 2.28 Billion USD | 21.52% |
| 2023 Q2 | 1.88 Billion USD | 13.44% |
| 2023 FY | 2.74 Billion USD | 83.1% |
| 2023 Q4 | 2.74 Billion USD | 19.85% |
| 2022 Q2 | 1.2 Billion USD | -0.9% |
| 2022 Q1 | 1.21 Billion USD | 0.19% |
| 2022 FY | 1.49 Billion USD | 23.04% |
| 2022 Q4 | 1.49 Billion USD | 7.85% |
| 2022 Q3 | 1.38 Billion USD | 14.9% |
| 2021 Q3 | 1.12 Billion USD | 1.39% |
| 2021 FY | 1.21 Billion USD | 21.37% |
| 2021 Q1 | 1 Billion USD | -0.02% |
| 2021 Q2 | 1.1 Billion USD | 10.42% |
| 2021 Q4 | 1.21 Billion USD | 8.43% |
| 2020 Q1 | 1.58 Billion USD | 58.6% |
| 2020 Q2 | 1.35 Billion USD | -14.51% |
| 2020 Q3 | 1.39 Billion USD | 3.15% |
| 2020 Q4 | 1 Billion USD | -28.21% |
| 2020 FY | 1 Billion USD | 0.41% |
| 2019 Q1 | 1.53 Billion USD | -21.69% |
| 2019 FY | 998.34 Million USD | -49.18% |
| 2019 Q2 | 1.47 Billion USD | -4.34% |
| 2019 Q3 | 1.33 Billion USD | -9.0% |
| 2019 Q4 | 998.34 Million USD | -25.45% |
| 2018 Q3 | 2.15 Billion USD | -0.9% |
| 2018 Q2 | 2.17 Billion USD | 10.58% |
| 2018 Q1 | 1.96 Billion USD | 18.17% |
| 2018 FY | 1.96 Billion USD | 17.9% |
| 2018 Q4 | 1.96 Billion USD | -8.96% |
| 2017 Q1 | 1.39 Billion USD | 14.76% |
| 2017 FY | 1.66 Billion USD | 36.69% |
| 2017 Q4 | 1.66 Billion USD | 7.03% |
| 2017 Q3 | 1.55 Billion USD | 11.01% |
| 2017 Q2 | 1.4 Billion USD | 0.26% |
| 2016 Q4 | 1.21 Billion USD | 14.06% |
| 2016 Q2 | 955.05 Million USD | -13.78% |
| 2016 Q1 | 1.1 Billion USD | 36.79% |
| 2016 FY | 1.21 Billion USD | 50.53% |
| 2016 Q3 | 1.06 Billion USD | 11.89% |
| 2015 Q4 | 809.71 Million USD | 1.41% |
| 2015 FY | 809.71 Million USD | 10.69% |
| 2015 Q3 | 798.44 Million USD | 8.53% |
| 2015 Q2 | 735.66 Million USD | -11.51% |
| 2015 Q1 | 831.37 Million USD | 13.65% |
| 2014 Q2 | 755.88 Million USD | -4.53% |
| 2014 Q3 | 825.4 Million USD | 9.2% |
| 2014 Q4 | 731.49 Million USD | -11.38% |
| 2014 Q1 | 791.71 Million USD | 63.18% |
| 2014 FY | 731.49 Million USD | 50.77% |
| 2013 FY | 485.18 Million USD | -9.02% |
| 2013 Q4 | 485.18 Million USD | 18.98% |
| 2013 Q3 | 407.79 Million USD | -12.9% |
| 2013 Q2 | 468.19 Million USD | -28.26% |
| 2013 Q1 | 652.58 Million USD | 22.37% |
| 2012 Q1 | 481.09 Million USD | 9.0% |
| 2012 Q3 | 609.38 Million USD | 13.9% |
| 2012 Q2 | 535 Million USD | 11.21% |
| 2012 FY | 533.27 Million USD | 20.83% |
| 2012 Q4 | 533.27 Million USD | -12.49% |
| 2011 Q2 | 443.34 Million USD | -13.58% |
| 2011 FY | 441.35 Million USD | 0.01% |
| 2011 Q4 | 441.35 Million USD | 2.18% |
| 2011 Q3 | 431.95 Million USD | -2.57% |
| 2011 Q1 | 513.01 Million USD | 16.25% |
| 2010 Q2 | 548.89 Million USD | 0.07% |
| 2010 FY | 441.3 Million USD | 64.75% |
| 2010 Q1 | 548.52 Million USD | 104.78% |
| 2010 Q4 | 441.3 Million USD | -27.63% |
| 2010 Q3 | 609.75 Million USD | 11.09% |
| 2009 FY | 267.86 Million USD | -37.41% |
| 2009 Q2 | 417.49 Million USD | 1.02% |
| 2009 Q3 | 268.17 Million USD | -35.77% |
| 2009 Q4 | 267.86 Million USD | -0.12% |
| 2009 Q1 | 413.28 Million USD | -3.43% |
| 2008 FY | 427.98 Million USD | -6.26% |
| 2008 Q4 | 427.98 Million USD | -0.24% |
| 2008 Q1 | 458.58 Million USD | 0.44% |
| 2008 Q2 | 454.3 Million USD | -0.93% |
| 2008 Q3 | 429.01 Million USD | -5.57% |
| 2007 Q3 | 464.18 Million USD | -3.39% |
| 2007 FY | 456.57 Million USD | -8.57% |
| 2007 Q1 | 497.17 Million USD | -0.44% |
| 2007 Q2 | 480.45 Million USD | -3.36% |
| 2007 Q4 | 456.57 Million USD | -1.64% |
| 2006 Q4 | 499.37 Million USD | -0.06% |
| 2006 FY | 499.37 Million USD | -4.81% |
| 2006 Q3 | 499.65 Million USD | -3.81% |
| 2006 Q2 | 519.45 Million USD | -0.55% |
| 2006 Q1 | 522.31 Million USD | -0.44% |
| 2005 FY | 524.62 Million USD | -2.04% |
| 2005 Q2 | 531.61 Million USD | 0.89% |
| 2005 Q3 | 524.4 Million USD | -1.36% |
| 2005 Q4 | 524.62 Million USD | 0.04% |
| 2005 Q1 | 526.94 Million USD | -1.61% |
| 2004 Q2 | 509.02 Million USD | 77.28% |
| 2004 Q4 | 535.55 Million USD | 0.39% |
| 2004 Q3 | 533.48 Million USD | 4.81% |
| 2004 Q1 | 287.12 Million USD | 11.98% |
| 2004 FY | 535.55 Million USD | 108.87% |
| 2003 FY | 256.41 Million USD | 2.56% |
| 2003 Q4 | 256.41 Million USD | 0.07% |
| 2003 Q3 | 256.22 Million USD | -0.21% |
| 2003 Q1 | 248.68 Million USD | -0.53% |
| 2003 Q2 | 256.75 Million USD | 3.25% |
| 2002 Q2 | 249.45 Million USD | 0.1% |
| 2002 Q3 | 250.88 Million USD | 0.57% |
| 2002 Q4 | 250.01 Million USD | -0.35% |
| 2002 FY | 250.01 Million USD | -4.36% |
| 2002 Q1 | 249.21 Million USD | -4.67% |
| 2001 Q1 | 266.63 Million USD | -3.64% |
| 2001 Q4 | 261.41 Million USD | -2.45% |
| 2001 FY | 261.41 Million USD | -5.52% |
| 2001 Q3 | 267.98 Million USD | 1.31% |
| 2001 Q2 | 264.51 Million USD | -0.79% |
| 2000 Q3 | 305.78 Million USD | -5.43% |
| 2000 Q4 | 276.69 Million USD | -9.51% |
| 2000 Q1 | 349.96 Million USD | -3.75% |
| 2000 Q2 | 323.34 Million USD | -7.61% |
| 2000 FY | 276.69 Million USD | -23.9% |
| 1999 FY | 363.6 Million USD | 73.64% |
| 1999 Q4 | 363.6 Million USD | 5.3% |
| 1999 Q3 | 345.3 Million USD | -5.37% |
| 1999 Q2 | 364.9 Million USD | -1.0% |
| 1999 Q1 | 368.6 Million USD | 76.03% |
| 1998 Q1 | 143.4 Million USD | 25.24% |
| 1998 Q3 | 209.7 Million USD | 43.43% |
| 1998 Q4 | 209.4 Million USD | -0.14% |
| 1998 FY | 209.4 Million USD | 82.88% |
| 1998 Q2 | 146.2 Million USD | 1.95% |
| 1997 Q2 | 61.2 Million USD | 58.14% |
| 1997 FY | 114.5 Million USD | 187.69% |
| 1997 Q4 | 114.5 Million USD | 23.92% |
| 1997 Q1 | 38.7 Million USD | -2.76% |
| 1997 Q3 | 92.4 Million USD | 50.98% |
| 1996 Q4 | 39.8 Million USD | 2.84% |
| 1996 Q1 | 55.6 Million USD | 29.0% |
| 1996 Q2 | 36.7 Million USD | -33.99% |
| 1996 Q3 | 38.7 Million USD | 5.45% |
| 1996 FY | 39.8 Million USD | -7.66% |
| 1995 Q4 | 43.1 Million USD | 0.0% |
| 1995 FY | 43.1 Million USD | -29.46% |
| 1994 FY | 61.1 Million USD | 0.0% |
| 1994 Q4 | 61.1 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -22774.072% |
| Accuray Incorporated | 172.15 Million USD | -1492.161% |
| Align Technology, Inc. | 96.96 Million USD | -2726.706% |
| Elevance Health Inc. | 25.12 Billion USD | 89.088% |
| AxoGen, Inc. | 69.29 Million USD | -3855.724% |
| Boston Scientific Corporation | 9.09 Billion USD | 69.869% |
| CVS Health Corporation | 79.38 Billion USD | 96.547% |
| Cardinal Health, Inc. | 5.6 Billion USD | 51.132% |
| Centene Corporation | 17.69 Billion USD | 84.513% |
| DaVita Inc. | 11.11 Billion USD | 75.343% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 93.452% |
| Hologic, Inc. | 2.53 Billion USD | -8.143% |
| Humana Inc. | 10.21 Billion USD | 73.162% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | -189.172% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | 53.965% |
| Masimo Corporation | 970 Million USD | -182.577% |
| McKesson Corporation | 5.47 Billion USD | 49.909% |
| Patterson Companies, Inc. | 762.94 Million USD | -259.268% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | 48.948% |
| ResMed Inc. | 873.93 Million USD | -213.639% |
| Teladoc Health, Inc. | 1.59 Billion USD | -72.143% |
| Universal Health Services, Inc. | 5.36 Billion USD | 48.925% |
| Veeva Systems Inc. | 55.77 Million USD | -4814.388% |
| Baxter International Inc. | 14.36 Billion USD | 80.918% |
| Becton, Dickinson and Company | 15.87 Billion USD | 82.738% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -2952.339% |
| Danaher Corporation | 19.35 Billion USD | 85.839% |
| Stryker Corporation | 12.99 Billion USD | 78.907% |
| Medtronic plc | 24.96 Billion USD | 89.02% |